SEC 13F Intelligence

Aristotle Atlantic Partners, LLC / LLY

Aristotle Atlantic Partners, LLC’s Eli Lilly & Co Position

Does Aristotle Atlantic Partners, LLC own Eli Lilly & Co (LLY)? Yes28.4K shares worth $26M (+1.22% of its 13F portfolio) as of Q1 2026, down from 28.6K shares the prior filed quarter.

Position Value
$26M
Q1 2026
Shares
28.4K
% of Portfolio
+1.22%
Quarters Held
12
currently held

Position History LLY

Reported value by quarter
Q2 ’23: $234,490Q2 ’23Q3 ’23: $268,565Q4 ’23: $4MQ4 ’23Q1 ’24: $6MQ2 ’24: $21MQ2 ’24Q3 ’24: $23MQ4 ’24: $32MQ4 ’24Q1 ’25: $36MQ2 ’25: $49MQ2 ’25Q3 ’25: $52MQ4 ’25: $31MQ4 ’25Q1 ’26: $26Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202628.4K$26M+1.22%
Q4 202528.6K$31M+1.41%
Q3 202568.0K$52M+1.50%
Q2 202562.5K$49M+1.48%
Q1 202543.2K$36M+1.20%
Q4 202441.2K$32M+1.00%
Q3 202425.6K$23M+0.70%
Q2 202422.8K$21M+0.67%
Q1 20248.3K$6M+0.21%
Q4 20236.1K$4M+0.13%
Q3 2023500$268,565+0.01%
Q2 2023500$234,490+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aristotle Atlantic Partners, LLC’s full portfolio or all institutional holders of LLY.